Published in Cancer Weekly, July 18th, 2006
Study 1: Astrocytoma could be treated by hypofractionated high-dose irradiation.
According to recent research from Japan, "We evaluated the clinical significance of hypofractionated high-dose irradiation using simultaneous integrated boost technique with intensity-modulated radiation therapy (IMRT) for the treatment of malignant astrocytomas (MAs). Twenty-five patients with MAs were treated by IMRT. Three layered planning target volumes (PTVs) were contoured."
"PTV-1 was the area of enhanced lesion with 5-mm margin; PTV-2 was the area with...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.